The world’s first meatball made from mammoth DNA has been revealed at the Nemo Science Museum in the Netherlands - a scientific experiment and creative collaboration between Wunderman Thompson Benelux, Australian cultured meat start-up Vow, Wefilm and a group of international experts to demonstrate
Dive Brief:
A committee that advises Europe s drug regulator is recommending that a gene therapy developed by Bluebird bio for a rare, often deadly disease be approved for market.
The disease, known as adrenoleukodystrophy or ALD for short, is caused by genetic mutations that lead to a toxic buildup of molecules in the brain and spinal cord. In clinical testing, Bluebird s therapy, now called Skysona, has shown positive effects on cerebral ALD the most common and severe form of the disease with the vast majority of treated patients staying alive and free of major functional disabilities.
The European Medicines Agency is now advising the European Commission to authorize Skysona for the treatment of early cerebral ALD in children with certain genetic mutations who don t have a sibling that can be a match for hematopoietic stem cell donation. Bluebird says a final decision is expected in mid-2021.